Drug companies frame rules to work with NHS
http://www.100md.com
《英国医生杂志》
The NHS needs to overcome reservations to work in greater partnership with drug companies, a document launched by the Association of the British Pharmaceutical Industry (ABPI) last week says. The guidelines aim to provide a framework for future joint working initiatives between drug companies and primary care organisations.
The Framework for Joint Working is the result of a collaboration between ABPI and the NHS Alliance, which represents primary care trusts. Several hundred senior staff at primary care organisations across the United Kingdom were interviewed, and the findings paint a complex picture of the current state of relations between the industry and the NHS.
"Some PCOs are very sceptical about the role and motives of the pharmaceutical industry," admits Kevin Jones, managing director of Wyeth Pharmaceuticals and chair of the working group responsible for the document. "Some PCOs have strong positive experiences of working with the industry, but some have not. Through talking to staff we have been able to understand their reservations and concerns more deeply and to spread examples of best practice."
The document cites the government's NHS Plan of 2000, which argued for greater collaboration with the private sector, and includes a written endorsement by the primary care tsar, Dr David Colin-Thome.
"Some people do have philosophical problems with the idea of joint working," says Mr Michael Sobanja, chief executive of the NHS Alliance. But he argues that the key to effective cooperation between the public and private sector lies in well managed projects with clear aims. "Often people simply do not know the best way to go about joint working. It has had a chequered history because in the past both parties have entered into initiatives without a clear idea of what they wanted to get out of them."
In particular, the ABPI document argues that the industry's expertise and resources can enhance education and training, and provide support in prescribing and conducting medication reviews.(Madeleine Brettingham)
The Framework for Joint Working is the result of a collaboration between ABPI and the NHS Alliance, which represents primary care trusts. Several hundred senior staff at primary care organisations across the United Kingdom were interviewed, and the findings paint a complex picture of the current state of relations between the industry and the NHS.
"Some PCOs are very sceptical about the role and motives of the pharmaceutical industry," admits Kevin Jones, managing director of Wyeth Pharmaceuticals and chair of the working group responsible for the document. "Some PCOs have strong positive experiences of working with the industry, but some have not. Through talking to staff we have been able to understand their reservations and concerns more deeply and to spread examples of best practice."
The document cites the government's NHS Plan of 2000, which argued for greater collaboration with the private sector, and includes a written endorsement by the primary care tsar, Dr David Colin-Thome.
"Some people do have philosophical problems with the idea of joint working," says Mr Michael Sobanja, chief executive of the NHS Alliance. But he argues that the key to effective cooperation between the public and private sector lies in well managed projects with clear aims. "Often people simply do not know the best way to go about joint working. It has had a chequered history because in the past both parties have entered into initiatives without a clear idea of what they wanted to get out of them."
In particular, the ABPI document argues that the industry's expertise and resources can enhance education and training, and provide support in prescribing and conducting medication reviews.(Madeleine Brettingham)